CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0

CUSIP: 229678AH0

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Debt / NOTE 1.875% 9/0
Market price (% of par)
111.39%
Total 13F principal
$399,742,587
Principal change
+$376,524,587
Total reported market value
$444,770,198
Number of holders
30
Value change
+$418,843,198
Number of buys
29

Quarterly Holders Quick Answers

What is CUSIP 229678AH0?
CUSIP 229678AH0 identifies 229678AH0 - CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 as of Q3 2014

As of 30 Sep 2014, CUBIST PHARMACEUTICALS INC - NOTE 1.875% 9/0 was held by 30 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $399,742,587 in principal (par value) of the bond. The largest 10 bondholders included FMR LLC, Invesco Ltd., ROYAL BANK OF CANADA, ADVENT CAPITAL MANAGEMENT /DE/, Lombard Odier Asset Management (Europe) Ltd, LORD, ABBETT & CO. LLC, AVIVA PLC, Calamos Advisors LLC, Ameriprise Financial Inc, and OAKTREE CAPITAL MANAGEMENT LP. This page lists 30 institutional bondholders reporting positions for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.